Utilización de aditivos para mejorar la sensibilidad de las mezclas bituminosas al calentamiento con microondas

This study examines the potential of adding electric arc furnace slag to bituminous mixtures to be heated by microwaves. The susceptibility of bituminous mixtures to microwave energy is limited and so, in order to improve the energy performance of the heating process, it is necessary to incorporate additives or components to the mixture so as to improve the capacity for microwave heating. The article presents the results of adding various components, (steel wool, scrap tire wire, silicon carbide, iron filings) and an alternative aggregate: electric arc furnace slag. According to the results obtained in the laboratory, slag addition of at least 5% by weight of the bituminous mixture represents the best option for both technical and economic reasons. The results may promote the valorization of this steel industry residue in bituminous mixtures by improving microwave heating response.El presente trabajo examina el potencial de añadir escorias siderúrgicas de horno de arco eléctrico en mezclas bituminosas cuando se calientan con energía de microondas. La susceptibilidad de las mezclas bituminosas a las microondas es limitada y con el objetivo de incrementarla es necesario incorporar aditivos o componentes que sí son susceptibles. El artículo presenta los resultados obtenidos con varios aditivos (lana de acero, alambre metálico reciclado de neumáticos fuera de uso, carburo de silíceo y limaduras de hierro) y un árido alternativo: escorias de horno de arco eléctrico. De acuerdo con los resultados obtenidos en el estudio, la incorporación de escorias en al menos un 5% en masa de la mezcla bituminosa representa la mejor opción por motivos técnicos y económicos. Este resultado puede potenciar la valorización de este residuo de la industria del acero en mezclas bituminosas para mejorar su respuesta al calentamiento con energía microondas

Segmented software cost estimation models based on fuzzy clustering

Parametric software cost estimation models are based on mathematical relations, obtained from the study of historical software projects databases, that intend to be useful to estimate the effort and time required to develop a software product. Those databases often integrate data coming from projects of a heterogeneous nature. This entails that it is difficult to obtain a reasonably reliable single parametric model for the range of diverging project sizes and characteristics. A solution proposed elsewhere for that problem was the use of segmented models in which several models combined into a single one contribute to the estimates depending on the concrete characteristic of the inputs. However, a second problem arises with the use of segmented models, since the belonging of concrete projects to segments or clusters is subject to a degree of fuzziness, i.e. a given project can be considered to belong to several segments with different degrees. This paper reports the first exploration of a possible solution for both problems together, using a segmented model based on fuzzy clusters of the project space. The use of fuzzy clustering allows obtaining different mathematical models for each cluster and also allows the items of a project database to contribute to more than one cluster, while preserving constant time execution of the estimation process. The results of an evaluation of a concrete model using the ISBSG 8 project database are reported, yielding better figures of adjustment than its crisp counterpart.Ministerio de Ciencia y Tecnología TIN2004-06689-C0

Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab : the BEYOND study (GEMCAD 17-01)

Altres ajuts: Fundació la Marató de TV3 (201330.10); Fundacion Olga Torres (Modalitat A. 2019/2020); Spanish Association Against Cancer (AECC, PROYE19040POST_001).Purpose: Panitumumab plus FOLFOX (P-FOLFOX) is standard first-line treatment for RAS wild-type (WT) metastatic colorectal cancer. The value of panitumumab rechallenge is currently unknown. We assessed addition of panitumumab to FOLFIRI (P-FOLFIRI) beyond progression to P-FOLFOX in patients with no RAS mutations in liquid biopsy (LB). Methods: In this randomized phase II trial, patients were assigned (3:2 ratio) to second-line P-FOLFIRI (arm A) or FOLFIRI alone (arm B). LB for circulating tumor DNA analysis was collected at study entry and at disease progression. Primary endpoint was 6-month progression-free survival. Two-stage Simon design required 85 patients to be included (EudraCT 2017-004519-38). Results: Between February 2019 and November 2020, 49 patients were screened (16 RAS mutations in LB detected) and 31 included (18 assigned to arm A and 13 to arm B). The study was prematurely closed due to inadequate recruitment. Serious adverse events were more frequent in arm A (44% vs. 23%). Overall response rate was 33% (arm A) vs. 7.7% (arm B). Six-month progression-free survival rate was 66.7% (arm A) and 38.5% (arm B). Median progression-free survival was 11.0 months (arm A) and 4.0 months (arm B) (hazard ratio, 0.58). At disease progression, RAS or BRAF mutations in LB were found in 4/11 patients (36%) in arm A and 2/10 (20%) in arm B. Conclusions: The BEYOND study suggests a meaningful benefit of P-FOLFIRI beyond progression to P-FOLFOX in metastatic colorectal cancer patients with WT RAS status selected by LB. This strategy deserves further investigation

Bronchoscopist's perception of the quality of the single-use bronchoscope (Ambu aScope4™) in selected bronchoscopies: a multicenter study in 21 Spanish pulmonology services

Background: The disposable bronchoscope is an excellent alternative to face the problem of SARS-CoV-2 and other cross infections, but the bronchoscopist's perception of its quality has not been evaluated. Methods: To evaluate the quality of the Ambu-aScope4 disposable bronchoscope, we carried out a cross-sectional study in 21 Spanish pulmonology services. We use a standardized questionnaire completed by the bronchoscopists at the end of each bronchoscopy. The variables were described with absolute and relative frequencies, measures of central tendency and dispersion depending on their nature. The existence of learning curves was evaluated by CUSUM analysis. Results: The most frequent indications in 300 included bronchoscopies was bronchial aspiration in 69.3% and the median duration of these was 9.1 min. The route of entry was nasal in 47.2% and oral in 34.1%. The average score for ease of use, image, and aspiration quality was 80/100. All the planned techniques were performed in 94.9% and the bronchoscopist was satisfied in 96.6% of the bronchoscopies. They highlighted the portability and immediacy of the aScope4TM to start the procedure in 99.3%, the possibility of taking and storing images in 99.3%. The CUSUM analysis showed average scores > 70/100 from the first procedure and from the 9th procedure more than 80% of the scores exceeded the 80/100 score. Conclusions: The aScope4™ scored well for ease of use, imaging, and aspiration. We found a learning curve with excellent scores from the 9th procedure. Bronchoscopists highlighted its portability, immediacy of use and the possibility of taking and storing images

MEGARA, the new intermediate-resolution optical IFU and MOS for GTC: getting ready for the telescope

MEGARA (Multi-Espectrógrafo en GTC de Alta Resolución para Astronomía) is an optical Integral-Field Unit (IFU) and Multi-Object Spectrograph (MOS) designed for the GTC 10.4m telescope in La Palma that is being built by a Consortium led by UCM (Spain) that also includes INAOE (Mexico), IAA-CSIC (Spain), and UPM (Spain). The instrument is currently finishing AIV and will be sent to GTC on November 2016 for its on-sky commissioning on April 2017. The MEGARA IFU fiber bundle (LCB) covers 12.5x11.3 arcsec2 with a spaxel size of 0.62 arcsec while the MEGARA MOS mode allows observing up to 92 objects in a region of 3.5x3.5 arcmin2 around the IFU. The IFU and MOS modes of MEGARA will provide identical intermediate-to-high spectral resolutions (RFWHM~6,000, 12,000 and 18,700, respectively for the low-, mid- and high-resolution Volume Phase Holographic gratings) in the range 3700-9800ÅÅ. An x-y mechanism placed at the pseudo-slit position allows (1) exchanging between the two observing modes and (2) focusing the spectrograph for each VPH setup. The spectrograph is a collimator-camera system that has a total of 11 VPHs simultaneously available (out of the 18 VPHs designed and being built) that are placed in the pupil by means of a wheel and an insertion mechanism. The custom-made cryostat hosts a 4kx4k 15-μm CCD. The unique characteristics of MEGARA in terms of throughput and versatility and the unsurpassed collecting are of GTC make of this instrument the most efficient tool to date to analyze astrophysical objects at intermediate spectral resolutions. In these proceedings we present a summary of the instrument characteristics and the results from the AIV phase. All subsystems have been successfully integrated and the system-level AIV phase is progressing as expected

Bronchoscopist's perception of the quality of the single-use bronchoscope (Ambu aScope4™) in selected bronchoscopies: a multicenter study in 21 Spanish pulmonology services

Background: The disposable bronchoscope is an excellent alternative to face the problem of SARS-CoV-2 and other cross infections, but the bronchoscopist’s perception of its quality has not been evaluated. Methods: To evaluate the quality of the Ambu-aScope4 disposable bronchoscope, we carried out a cross-sectional study in 21 Spanish pulmonology services. We use a standardized questionnaire completed by the bronchoscopists at the end of each bronchoscopy. The variables were described with absolute and relative frequencies, measures of cen‑ tral tendency and dispersion depending on their nature. The existence of learning curves was evaluated by CUSUM analysis. Results: The most frequent indications in 300 included bronchoscopies was bronchial aspiration in 69.3% and the median duration of these was 9.1 min. The route of entry was nasal in 47.2% and oral in 34.1%. The average score for ease of use, image, and aspiration quality was 80/100. All the planned techniques were performed in 94.9% and the bronchoscopist was satisfed in 96.6% of the bronchoscopies. They highlighted the portability and immediacy of the aScope4TM to start the procedure in 99.3%, the possibility of taking and storing images in 99.3%. The CUSUM analysis showed average scores>70/100 from the frst procedure and from the 9th procedure more than 80% of the scores exceeded the 80/100 score

MEGARA anti-reflective coatings: theoretical and observed throughput estimations

MEGARA is the new integral field unit (IFU) and multi-object (MOS) spectrograph successfully commissioned at Gran Telescopio Canarias, in August 2017. MEGARA provides spectral resolutions R (fwhm) ~ 6000, 12000 and 20000, via volume phase holographic gratings, at very high efficiency in both IFU and MOS modes. In the case of MEGARA main optics and pupil elements optics, the surfaces in contact with air have an anti-reflective (AR) coatings to minimize the Fresnel losses at the interface glass-air. In this work we present the designs and calculation of the total throughput of the optical system based in the transmission measurements of the AR coated witness samples. The results reflect the benefits of having implemented customized AR coatings for the mean angle of incidence on each surface as the measured throughput was better than the requirements. We analyze the effects of the pupil elements AR coatings for each spectral configuration. © 2018 SPI

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)

Colorectal cancer (CRC) is the second cause of cancer death in Spain, the objective of this guide published by the Spanish Society of Medical Oncology is to develop a consensus for the diagnosis and management of metastatic disease. The optimal treatment strategy for patients with metastatic CRC should be discussed in a multidisciplinary expert team to select the most appropriate treatment, and integrate systemic treatment and other options such as surgery and ablative techniques depending on the characteristics of the tumour, the patient and the location of the disease and metastases

MEGARA Spectrograph Optics

MEGARA is the next optical Integral-Field Unit (IFU) and Multi-Object Spectrograph (MOS) for Gran Telescopio Canarias. The instrument offers two IFUs plus a Multi-Object Spectroscopy (MOS) mode: a large compact bundle covering 12.5 arcsec x 11.3 arcsec on sky with 100 μm fiber-core; a small compact bundle, of 8.5 arcsec x 6.7 arcsec with 70 μm fiber-core and a fiber MOS positioner that allows to place up to 100 mini-bundles, 7 fibers each, with 100 μm fiber-core, within a 3.5 arcmin x 3.5 arcmin field of view, around the two IFUs. The fibers, organized in bundles, end in the pseudo-slit plate, which will be placed at the entrance focal plane of the MEGARA spectrograph. The large IFU and MOS modes will provide intermediate to high spectral resolutions, R=6800-17000. The small IFU mode will provide R=8000-20000. All these resolutions are possible thanks to a spectrograph design based in the used of volume phase holographic gratings in combination with prisms to keep fixed the collimator and camera angle. The MEGARA optics is composed by a total of 53 large optical elements per spectrograph: the field lens, the collimator and the camera lenses plus the complete set of pupil elements including holograms, windows and prisms. INAOE, a partner of the GTC and a partner of MEGARA consortium, is responsible of the optics manufacturing and tests. INAOE will carry out this project working in an alliance with CIO. This paper summarizes the status of MEGARA spectrograph optics at the Preliminary Design Review, held on March 2012